Age ≥ 65 years
|
49 (49%)
Mean=61, Median=64
|
240 (46%)
Mean=61, Median=64
|
88 (37%)
|
Female sex |
50 (50%) |
269 (52%) |
58 (22%) |
BMI ≥ 30 kg/m2
|
34 (34%)
Mean=29, Median=28
|
210 (40%)
Mean=29, Median=28
|
70 (33%)
|
Ischemic cardiomyopathy and/or hypertension |
52 (52%) |
297
(57%) |
35 (12%) |
Arrhythmia |
12 (12%) |
75 (14%) |
27 (36%) |
Thyroid disturbances |
29 (29%) |
152 (29%) |
36
(24%) |
Liver failure
|
3 (3%)
|
17 (3%)
|
17 (100%)
11 (65%) had higher baseline ECG
|
Neurological disorders |
0 (0%) |
0 (0%) |
0
(0%) |
Diabetes |
41 (41%) |
221 (41%) |
57 (26%) |
Potassium ≤ 3.5 mmol/L
|
23 (23%)
|
83 (16%)
Mean=3.75, Median=4
|
29 (35%)
|
Calcium < 2.15 mmol/L
|
21 (21%)
|
81 (16%)
Mean=9, Median=9.1
|
17 (21%)
|
CRP > 5 mg/L
|
16 (16%)
|
97 (19%)
Mean=89, Median=82
402 missing values
|
35 (36%)
|
eGFR ≤ 30 ml/min
|
7 (7%)
|
48 (9%)
Mean=89, Median=90
|
5 (10%)
|
List 1 QT-drug CredibleMeds |
82 (82%) 1-4 drugs/patient |
386
(74%) |
105 (27%) |
List 2 QT-drug CredibleMeds |
62 (62%) 1-3 drugs/patient |
235
(45%) |
52 (22%) |
List 3 QT-drug CredibleMeds |
75 (75%) 1-6 drugs/patient |
397
(76%) |
116 (29%) |
Prolonged QTc (≥450(♂)/470(♀) ms) on previous ECG |
15 (15%) |
82 (16%) |
45 (55%) |